Full-spectrum Drug Discovery capabilities with the flexibility of agile and focused speciality teams
The problem > the solution
Our CONSORTIUM MODEL
Computational Assisted Drug Design - CADD
Medicinal chemistry, custom synthesis
Biological screening, HTS, in vitro assay Development
Genetic toxicology, GLP in vitro safety testing
1 single point
of contact
Specialist
depth
Optimized
costs
Transparent
collaboration
SERVICES OVERVIEW
WHO WE SERVE
You have an academic hit that needs industry-ready maturation
You have the science, but not the chemistry team, nor yet the roadmap to a candidate. We bring both
Outsourced chemistry, in-house trust: expertise, responsiveness and IP control, by design.
“The modified phosphoramidites synthesized by Oxeltis for our oligonucleotide program showed excellent purity and enhanced activity when tested in our systems. Timely synthesis and clear communication by Oxeltis greatly facilitated our project's progress.”
Joel Kaye, PhD, Chief Development Officer,
1E Therapeutics Ltd.
“Over the years, I have collaborated several times with Oxeltis, and I was very pleased with the timely delivery and the quality of the compounds they made”
Piet HERDEWYN, Prof. Em. Dr.
KUL, Catholic University of Leuven, Belgium
“My team and I have been collaborating with Oxeltis since 2014, successfully delivering a number of key medicinal chemistry projects […]. Throughout this collaboration, the Oxeltis team has consistently demonstrated strong expertise in the synthesis of complex organic molecules, alongside valuable contributions to compound design and SAR studies […]. Importantly, Oxeltis' medicinal and synthetic chemistry work has contributed to the selection of high-value clinical candidates.”
Adel Moussa, Executive Vice President, Chemistry,
Atea Pharmaceuticals, Boston, MA, USA
